EPA:SAN - Sanofi Stock Price, News, & Analysis

Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, an agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; and Allegra for seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. Sanofi has strategic alliance with Sensile Medical Ltd.; collaboration with Evotec AG; and partnership with REVOLUTION Medicines, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Sanofi (EPA:SAN) Frequently Asked Questions

What is Sanofi's stock symbol?

Sanofi trades on the EPA under the ticker symbol "SAN."

What price target have analysts set for SAN?

15 equities research analysts have issued 12 month price objectives for Sanofi's stock. Their forecasts range from €77.00 to €95.00. On average, they anticipate Sanofi's stock price to reach €85.73 in the next twelve months. View Analyst Price Targets for Sanofi.

What is the consensus analysts' recommendation for Sanofi?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sanofi.

Has Sanofi been receiving favorable news coverage?

Press coverage about SAN stock has trended neutral this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sanofi earned a news impact score of 0.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days.

Who are some of Sanofi's key competitors?

Some companies that are related to Sanofi include AstraZeneca (AZN), GlaxoSmithKline (GSK), Bayer (BAYN), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Opthea (OPT), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY) and Vita Life Sciences (VLS).

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include Encana (ECA), Tronox (TROX), Sanofi (SNY), Kontrol Energy (KNR), Baidu (BIDU), Arch Coal (ARCH), ImmunoGen (IMGN), Bank of America (BAC), Canopy Growth (CGC) and Total (TOT).

Who are Sanofi's key executives?

Sanofi's management team includes the folowing people:

• Mr. Olivier Brandicourt, CEO & Director (Age 63)
• Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 54)
• Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
• Mr. Bruno Ménard, Chief Information officer
• Mr. George Grofik, Head of Investor Relations

What is Sanofi's official website?

The official website for Sanofi is http://en.sanofi.com.

How can I contact Sanofi?

Sanofi's mailing address is 54 rue la Boetie, PARIS, 75008, France. The company can be reached via phone at +33-1-53774000.